These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 126043)

  • 21. 6-Aminohexanoic acid-plasminogen interactions studied by fluorescence.
    Vuk-Pavlović S; Gafni A
    Biochem Biophys Res Commun; 1979 Dec; 91(3):971-5. PubMed ID: 526295
    [No Abstract]   [Full Text] [Related]  

  • 22. Rabbit plasminogen and plasmin isozymes.
    Castellino FJ; Sodetz JM
    Methods Enzymol; 1976; 45():273-86. PubMed ID: 138065
    [No Abstract]   [Full Text] [Related]  

  • 23. The plasmin heavy chain-urokinase conjugate: a specific thrombolytic agent.
    Nakayama Y; Shinohara M; Tani T; Kawaguchi T; Furuta T; Izawa T; Kaise H; Miyazaki W; Nakano Y
    Thromb Haemost; 1986 Dec; 56(3):364-70. PubMed ID: 2951892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activation of plasminogen by tissue activators and the inhibitory effects of some anti-plasmin agents].
    Nagamatsu A; Hayashida T; Asakawa T
    Seikagaku; 1968 Aug; 40(8):357-62. PubMed ID: 4236329
    [No Abstract]   [Full Text] [Related]  

  • 25. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF; Houng A; Reed GL
    Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 30. [EXPERIMENT WITH A PLASMIN PREPARATION BY USING THE CASIN SPLITTING TEST: THE ACTION OF PLASMIN-NOVO AND ITS INHIBITION WITH EPSILON-AMINOCAPROIC ACID AND TRASYLOL].
    BERGHOFF A; GLATZEL H
    Thromb Diath Haemorrh; 1964 Dec; 12():418-24. PubMed ID: 14254701
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: On the primary structure of human plasminogen and plasmin, cyanogen bromide fragments.
    Wiman B; Wallén P
    Thromb Diath Haemorrh; 1975 Sep; 34(1):350. PubMed ID: 127402
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH; Summaria L; Robbins KC
    Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Location of the intermediate and high affinity omega-aminocarboxylic acid-binding sites in human plasminogen.
    Váli Z; Patthy L
    J Biol Chem; 1982 Feb; 257(4):2104-10. PubMed ID: 6915938
    [No Abstract]   [Full Text] [Related]  

  • 34. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen.
    Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y
    J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of native and lower molecular weight forms of sheep plasminogen.
    Paoni NF; Violand BN; Castellino FJ
    J Biol Chem; 1977 Nov; 252(21):7725-32. PubMed ID: 144130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kringle domains and plasmin denaturation.
    Shi GY; Wu DH; Wu HL
    Biochem Biophys Res Commun; 1991 Jul; 178(1):360-8. PubMed ID: 1829887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxynitrite and fibrinolytic system-The effects of peroxynitrite on t-PA-induced plasmin activity.
    Kolodziejczyk-Czepas J; Ponczek MB; Nowak P
    Int J Biol Macromol; 2015 Nov; 81():212-9. PubMed ID: 26234576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS.
    GANS H
    Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions of epsilon-aminocaproic acid with the thrombin clotting and fibrinolytic systems.
    Maxwell RE; Allen D
    Nature; 1966 Jan; 209(5019):211-3. PubMed ID: 4223693
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
    Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
    Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.